Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.
about
Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs.Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsAntiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Interactions between antifungal and antiretroviral agents.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Clinical Characteristics and Prognosis of Penicilliosis Among Human Immunodeficiency Virus-Infected Patients in Eastern China.Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil.Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavir.Disseminated histoplasmosis and aids: relapse and late mortality in endemic area in North-Eastern Brazil.Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.
P2860
Q34633457-699EB5FA-A99C-4AB2-8785-F43D47AA39ECQ35108410-94AB810D-F028-41BB-805E-6BE0438CA2CAQ35826931-E5629C75-B112-45A8-82C1-1416C4AB5CCEQ37378110-3BA7D908-ED28-4F48-8134-FE32EFA318D2Q37719545-F0BF6A9A-E5FD-4E21-B717-C0315C333EA5Q38103889-39BCC7BC-F2FA-4877-B13C-281CBF78D0E4Q40047750-4C08A09D-2124-4CA3-99E9-97C2A4A3FCC6Q42224893-A38A9B5D-D8E7-4065-A39D-17389B3D9AF3Q42429561-C6580FA7-D72F-48ED-AABC-DD80C38C1238Q43236620-0602C4AB-1E9D-4C6F-A4BD-2530A9620408Q44847967-02AFC91B-84A4-43A2-B013-CB69F69F124EQ46032916-8E468596-B254-40C2-8B67-77C146BDB2D3
P2860
Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Drug-drug interaction between ...... h disseminated histoplasmosis.
@en
Drug-drug interaction between ...... h disseminated histoplasmosis.
@nl
type
label
Drug-drug interaction between ...... h disseminated histoplasmosis.
@en
Drug-drug interaction between ...... h disseminated histoplasmosis.
@nl
prefLabel
Drug-drug interaction between ...... h disseminated histoplasmosis.
@en
Drug-drug interaction between ...... h disseminated histoplasmosis.
@nl
P2093
P2860
P356
P1476
Drug-drug interaction between ...... h disseminated histoplasmosis.
@en
P2093
Alwin D R Huitema
Jan H M Schellens
Jan W Mulder
Jos H Beijnen
Kristel M L Crommentuyn
Rolf W Sparidans
P2860
P356
10.1086/382675
P407
P577
2004-04-01T00:00:00Z